From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

Gut Microbiome Correlates of Response and Toxicity Following Anti-CD19 CAR T Cell Therapy

Investigators explored the role of the intestinal microbiome on outcomes in a multicenter study and concluded that changes in the intestinal microbiome are associated with clinical outcomes after anti-CD19 CAR T cell therapy in patients with B-cell malignancies.

Nature Medicine
Advertisement
News & Literature Highlights
Advertisement
Advertisement